<i>PTEN</i> deletion drives acute myeloid leukemia resistance to MEK inhibitors
Amanda M. Smith(University of Queensland), Andrew S. Moore(Children's Health Queensland Hospital and Health Service)
Cited by 12
Related Papers
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|369